What is Roth Capital’s Estimate for CAPR FY2026 Earnings?
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Analysts at Roth Capital issued their FY2026 EPS estimates for Capricor Therapeutics in a note issued to investors on Tuesday, May 20th. Roth Capital analyst B. Pachaiyappan anticipates that the biotechnology company will post earnings per share of ($0.72) for the year. Roth Capital currently has a […]
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Analysts at Roth Capital issued their FY2026 EPS estimates for Capricor Therapeutics in a note issued to investors on Tuesday, May 20th. Roth Capital analyst B. Pachaiyappan anticipates that the biotechnology company will post earnings per share of ($0.72) for the year. Roth Capital currently has a […]
